Suppr超能文献

针对寡聚体 Abeta40 生成的 RNA 适体以低特异性但高灵敏度识别常见的淀粉样蛋白适体。

RNA aptamers generated against oligomeric Abeta40 recognize common amyloid aptatopes with low specificity but high sensitivity.

机构信息

Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA.

出版信息

PLoS One. 2009 Nov 10;4(11):e7694. doi: 10.1371/journal.pone.0007694.

Abstract

Aptamers are useful molecular recognition tools in research, diagnostics, and therapy. Despite promising results in other fields, aptamer use has remained scarce in amyloid research, including Alzheimer's disease (AD). AD is a progressive neurodegenerative disease believed to be caused by neurotoxic amyloid beta-protein (Abeta) oligomers. Abeta oligomers therefore are an attractive target for development of diagnostic and therapeutic reagents. We used covalently-stabilized oligomers of the 40-residue form of Abeta (Abeta40) for aptamer selection. Despite gradually increasing the stringency of selection conditions, the selected aptamers did not recognize Abeta40 oligomers but reacted with fibrils of Abeta40, Abeta42, and several other amyloidogenic proteins. Aptamer reactivity with amyloid fibrils showed some degree of protein-sequence dependency. Significant fibril binding also was found for the naïve library and could not be eliminated by counter-selection using Abeta40 fibrils, suggesting that aptamer binding to amyloid fibrils was RNA-sequence-independent. Aptamer binding depended on fibrillogenesis and showed a lag phase. Interestingly, aptamers detected fibril formation with > or =15-fold higher sensitivity than thioflavin T (ThT), revealing substantial beta-sheet and fibril formation undetected by ThT. The data suggest that under physiologic conditions, aptamers for oligomeric forms of amyloidogenic proteins cannot be selected due to high, non-specific affinity of oligonucleotides for amyloid fibrils. Nevertheless, the high sensitivity, whereby aptamers detect beta-sheet formation, suggests that they can serve as superior amyloid recognition tools.

摘要

适体是研究、诊断和治疗中有用的分子识别工具。尽管在其他领域取得了有希望的结果,但适体在淀粉样蛋白研究中的应用仍然很少,包括阿尔茨海默病(AD)。AD 是一种进行性神经退行性疾病,据信是由神经毒性淀粉样β蛋白(Abeta)寡聚体引起的。因此,Abeta 寡聚体是开发诊断和治疗试剂的有吸引力的靶标。我们使用 Abeta (Abeta40)的 40 个残基形式的共价稳定寡聚物进行适体选择。尽管逐渐增加选择条件的严格性,但所选适体不识别 Abeta40 寡聚体,而是与 Abeta40、Abeta42 和几种其他淀粉样蛋白的纤维反应。适体与淀粉样纤维的反应表现出一定程度的蛋白质序列依赖性。还发现对原始文库具有显著的纤维结合,并且不能通过使用 Abeta40 纤维进行反选择来消除,这表明适体与淀粉样纤维的结合是 RNA 序列独立的。适体结合依赖于纤维形成,并显示出滞后期。有趣的是,与 ThT 相比,适体检测纤维形成的灵敏度高 15 倍以上,揭示了大量的β-折叠和纤维形成未被 ThT 检测到。数据表明,在生理条件下,由于寡核苷酸对淀粉样纤维的高非特异性亲和力,不能选择针对淀粉样蛋白寡聚体形式的适体。然而,适体的高灵敏度,即检测β-折叠形成的能力,表明它们可以作为优异的淀粉样蛋白识别工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e9d/2770325/250e66cbfa8d/pone.0007694.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验